Speakers will examine the rapidly evolving DOJ enforcement landscape in life sciences and healthcare. In 2025, False Claims Act recoveries exceeded $6.8 billion, with whistleblower-driven cases outpacing government-initiated matters for the first time. We will discuss emerging enforcement priorities, including criminal prosecution of digital health and telemedicine fraud, transnational organized crime, expanding Anti-Kickback Statute theories, and DOJ’s increasingly aggressive use of the False Claims Act to pursue both billing fraud and regulatory violations. We will also share practical strategies to help organizations stay ahead of escalating civil and criminal enforcement risk and strengthen compliance programs in this high-stakes environment.